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This supplement to The Journal of Infec-
tious Diseases is the result of the first In-
ternational Sepsis Forum (ISF) Cambridge
Colloquium, held at Queens College on
14 and 15 July 2002. The ISF is a nonprofit
nongovernmental organization whose
members are healthcare professionals in
critical care and infectious disease com-
mitted to improving the understanding
and clinical treatment of patients with se-
vere sepsis.
The first ISF Cambridge Colloquium
was designed to bring together leading ex-
perts on genetics and innate immunity in
sepsis for an open forum discussion. The
supplement contains manuscripts from
the outstanding faculty who participated
in the meeting. We thank them for their
superb contributions to the meeting and
this supplement. Their research and the re-
sults reported here provide new insights
into the cellular and genetic mechanisms
involved in sepsis and also lay the ground-
work for future therapies that will improve
patient outcome from this common and
unfortunately devastating clinical problem.
